Shin-ichi Fuchida
Koyama, 6038151, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.
Journal: British journal of haematology
Published: February 02, 2026
Salivary Microbiota From a Periodontitis Donor Is Associated With Altered IgA-Related Immune Features in Germ-Free Mice.
Journal: Journal of clinical periodontology
Published: November 07, 2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myeloma.
Journal: International journal of hematology
Published: July 02, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 29, 2025
Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: April 02, 2025
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study.
Journal: Haematologica
Published: January 22, 2025
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.
Journal: International journal of clinical oncology
Published: November 24, 2024
The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients.
Journal: Annals of hematology
Published: May 30, 2024
Regional Inequalities in Oral Frailty and Social Capital.
Journal: JDR clinical and translational research
Published: April 24, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: February 14, 2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Journal: Annals of hematology
Published: November 30, 2023
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).
Journal: International journal of hematology
Published: September 13, 2023
Last Updated: 09/26/2026